Newsroom
CONTACTS
Media: Sunny Uberoi, 212.994.8206
Investors: Robert Anstey, 800.962.2436
Recent Press Releases
| DATE |
TITLE (click to view) |
| May 1, 2008 | Antigenics Reports First Quarter 2008 Financial Results |
| April 24, 2008 | Antigenics To Report First Quarter 2008 Financial Results On May 1, 2008; Conference Call To Follow |
| April 9, 2008 | Antigenics to Raise $21 Million in Private Placement |
| April 8, 2008 | Oncophage® Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer |
| March 21, 2008 | Antigenics to Present Phase 3 Oncophage (vitespen) Data in Kidney Cancer at European Association of Urology Annual Congress |
| February 21, 2008 | Antigenics Reports Fourth Quarter and Year-End 2007 Financial Results and Highlights |
| February 20, 2008 | Antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of Clinical Oncology |
| February 14, 2008 | Antigenics to Report Fourth Quarter and Year-End 2007 Financial Results on February 21, 2008; Conference Call to Follow |
| January 9, 2008 | Antigenics Raises $26 Million in Private Placement |
| January 3, 2008 | Antigenics Reports Positive Data on QS-21 Stimulon® Adjuvant in Acambis’ Influenza A Vaccine |
| |
More news releases » |
|
|
Click to download the essential documents about Antigenics.
(1 MB .zip) |
|
|
